These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 18449463)

  • 1. A pilot study on genetic variation in purine-rich elements in the nephrin gene promoter in type 2 diabetic patients.
    González R; Tirado A; Balanda M; Alvo M; Barquín I; Durruty P; Lobos S; Seelenfreund D
    Biol Res; 2007; 40(3):357-64. PubMed ID: 18449463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin-10-592C/A, -819C/T and -1082A/G promoter variants affect the susceptibility to nephropathy in Tunisian type 2 diabetes (T2DM) patients.
    Ezzidi I; Mtiraoui N; Kacem M; Mallat SG; Mohamed MB; Chaieb M; Mahjoub T; Almawi WY
    Clin Endocrinol (Oxf); 2009 Mar; 70(3):401-7. PubMed ID: 18616700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A single nucleotide polymorphism alters the sequence of SP1 binding site in the adiponectin promoter region and is associated with diabetic nephropathy among type 1 diabetic patients in the Genetics of Kidneys in Diabetes Study.
    Zhang D; Ma J; Brismar K; Efendic S; Gu HF
    J Diabetes Complications; 2009; 23(4):265-72. PubMed ID: 18599322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of endothelial nitric oxide synthase Glu298Asp, 4b/a, and -786T>C gene variants with diabetic nephropathy.
    Ezzidi I; Mtiraoui N; Mohamed MB; Mahjoub T; Kacem M; Almawi WY
    J Diabetes Complications; 2008; 22(5):331-8. PubMed ID: 18413207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of the intronic single nucleotide polymorphism rs#466452 of the nephrin gene in patients with diabetic nephropathy.
    González R; Tirado A; Rojas LA; Ossandón FJ; Alvo M; Wolff C; Seelenfreund D; Durruty P; Lobos S
    Biol Res; 2009; 42(2):189-98. PubMed ID: 19746264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictive value of interleukin-10 promoter genotypes and haplotypes in determining the susceptibility to nephropathy in type 2 diabetes patients.
    Mtiraoui N; Ezzidi I; Kacem M; Ben Hadj Mohamed M; Chaieb M; Haj Jilani AB; Mahjoub T; Almawi WY
    Diabetes Metab Res Rev; 2009 Jan; 25(1):57-63. PubMed ID: 19031431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heat-shock protein gene polymorphisms and the risk of nephropathy in patients with Type 2 diabetes.
    Buraczynska M; Swatowski A; Buraczynska K; Dragan M; Ksiazek A
    Clin Sci (Lond); 2009 Jan; 116(1):81-6. PubMed ID: 18518860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship of angiotensin-converting enzyme gene polymorphism with nephropathy associated with Type 2 diabetes mellitus in Asian Indians.
    Movva S; Alluri RV; Komandur S; Vattam K; Eppa K; Mukkavali KK; Mubigonda S; Saharia S; Shastry JC; Hasan Q
    J Diabetes Complications; 2007; 21(4):237-41. PubMed ID: 17616353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glu298Asp and NOS4ab polymorphisms in diabetic nephropathy.
    Möllsten A; Wessman M; Svensson M; Forsblom C; Parkkonen M; Brismar K; Groop PH; Dahlquist G
    Ann Med; 2006; 38(7):522-8. PubMed ID: 17101543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Association of the hepatic lipase gene -250G/A promoter polymorphism with the susceptibility to type 2 diabetes mellitus combining with coronary heart disease].
    Wei M; Lu YS; Li PP
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2009 Apr; 26(2):219-22. PubMed ID: 19350521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Further evidence for the association of MMP9 with nephropathy in type 2 diabetes and application of DNA pooling technology to candidate gene screening.
    Nair S; Phillips AO; Norton N; Spurlock G; Williams HJ; Craig KJ; Williams JD; Williams NM; Bowen T
    J Nephrol; 2008; 21(3):400-5. PubMed ID: 18587729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apolipoprotein E polymorphism and expression in type 2 diabetic patients with nephropathy: clinicopathological correlation.
    Guan J; Zhao HL; Baum L; Sui Y; He L; Wong H; Lai FM; Tong PC; Chan JC
    Nephrol Dial Transplant; 2009 Jun; 24(6):1889-95. PubMed ID: 19218599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene polymorphisms and antigen levels of matrix metalloproteinase-1 in type 2 diabetes mellitus coexisting with coronary heart disease.
    Drzewoski J; Sliwińska A; Przybyłowska K; Sliwiński T; Kasznicki J; Zurawska-Klis M; Kosmalski M; Majsterek I
    Kardiol Pol; 2008 Oct; 66(10):1042-8; discussion 1049. PubMed ID: 19006025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential expression of nephrin according to glomerular size in early diabetic kidney disease.
    Kim JJ; Li JJ; Jung DS; Kwak SJ; Ryu DR; Yoo TH; Han SH; Choi HY; Kim HJ; Han DS; Kang SW
    J Am Soc Nephrol; 2007 Aug; 18(8):2303-10. PubMed ID: 17599973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel sequence variants in the human xylosyltransferase I gene and their role in diabetic nephropathy.
    Bahr C; Schön S; Kuhn J; Groop PH; Parkkonen M; Wessman M; Kleesiek K; Götting C
    Diabet Med; 2006 Jun; 23(6):681-4. PubMed ID: 16759312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apo E gene polymorphism on development of diabetic nephropathy.
    Ilhan N; Kahraman N; Seçkin D; Ilhan N; Colak R
    Cell Biochem Funct; 2007; 25(5):527-32. PubMed ID: 16933203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymorphism of the aldosterone synthase gene is not associated with progression of diabetic nephropathy, but associated with hypertension in type 2 diabetic patients.
    Ko GJ; Kang YS; Lee MH; Song HK; Kim HK; Cha DR
    Nephrology (Carlton); 2008 Dec; 13(6):492-9. PubMed ID: 18771471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. No support for association of protein kinase C, beta 1 (PRKCB1) gene promoter polymorphisms c.-1504C>T and c.-546C>G with diabetic nephropathy in Type 1 diabetes.
    Pettigrew KA; McKnight AJ; Martin RJ; Patterson CC; Kilner J; Sadlier D; Maxwell AP; Savage DA;
    Diabet Med; 2008 Sep; 25(9):1127-9. PubMed ID: 18937679
    [No Abstract]   [Full Text] [Related]  

  • 19. Methylenetetrahydrofolate reductase gene polymorphism is not related to diabetic nephropathy in Japanese Type 2 diabetic patients.
    Yoshioka K; Yoshida T; Umekawa T; Kogure A; Takakura Y; Toda H; Yoshikawa T
    Diabet Med; 2004 Sep; 21(9):1051-2. PubMed ID: 15317615
    [No Abstract]   [Full Text] [Related]  

  • 20. Vascular endothelial growth factor insertion/deletion gene polymorphism in West Indian patients of type 2 diabetes and diabetic nephropathy.
    Dabhi B; Mistry KN; Patel H; Lal S
    Indian J Biochem Biophys; 2015 Apr; 52(2):209-12. PubMed ID: 26118134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.